Septic arthritis caused by Moraxella catarrhalis associated with infliximab treatment in a patient with undifferentiated spondarthritis.
Olivieri
I
I
Padula
A
A
Armignacco
L
L
Sabatella
V
V
Mancino
M
M
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001170:Arthritis, Infectious / Q000139:chemically induced* / Q000382:microbiology; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D001936:Moraxella catarrhalis; D045828:Moraxellaceae Infections / Q000139:chemically induced*; D009894:Opportunistic Infections / Q000139:chemically induced* / Q000382:microbiology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab